BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17350269)

  • 21. [Indications and contraindications for radiosynoviorthesis].
    Beil FT; Rüther W
    Z Rheumatol; 2015 Nov; 74(9):780-5. PubMed ID: 26555659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of extraarticular leakage values of radiopharmaceuticals used for radionuclide synovectomy.
    Gedik GK; Uğur O; Atilla B; Pekmezci M; Yildirim M; Seven B; Varoğlu E
    Ann Nucl Med; 2006 Apr; 20(3):183-8. PubMed ID: 16715948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Radiosynoviorthesis. An efficient form of local treatment for inflammatory joint diseases].
    Gratz S; Göbel D; Behr TM
    Dtsch Med Wochenschr; 2002 Aug; 127(33):1704-7. PubMed ID: 12183804
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The co effect of prophylaxis and radiosynovectomy on bleeding episodes in haemophilic synovitis.
    Brecelj J; Bole V; Benedik-Dolnicar M; Grmek M
    Haemophilia; 2008 May; 14(3):513-7. PubMed ID: 18248407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy.
    Georg P; Kirisits C; Goldner G; Dörr W; Hammer J; Pötzi R; Berger D; Dimopoulos J; Georg D; Pötter R
    Radiother Oncol; 2009 May; 91(2):173-80. PubMed ID: 19243846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Local treatment of chronic arthritis with radionuclides].
    Bahous I; Müller W
    Schweiz Med Wochenschr; 1976 Aug; 106(32):1065-73. PubMed ID: 1006230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bone and joint tuberculosis concurrent with tuberculosis of other organs].
    Yagi O; Kawabe Y; Nagayama N; Shimada M; Kawashima M; Kaneko Y; Ariga H; Ohshima N; Matsui Y; Suzuki J; Masuda K; Tamura A; Nagai H; Akagawa S; Machida K; Kurashima A; Nakajima Y; Yotsumoto H
    Kekkaku; 2007 Jun; 82(6):523-9. PubMed ID: 17633120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does timing of androgen deprivation influence radiation-induced toxicity? A secondary analysis of radiation therapy oncology group protocol 9413.
    Taussky D; Bae K; Bahary JP; Roach M; Lawton CA; Shipley WU; Sandler HM
    Urology; 2008 Nov; 72(5):1125-9. PubMed ID: 18314175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcome of adjuvant treatment of endometrial cancer using aperture-based intensity-modulated radiotherapy.
    Bouchard M; Nadeau S; Gingras L; Raymond PE; Beaulieu F; Beaulieu L; Fortin A; Germain I
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1343-50. PubMed ID: 18294780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
    Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.
    Lee HK; Adams MT; Motta J
    Brachytherapy; 2008; 7(1):17-21. PubMed ID: 18201939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic status of radiosynoviorthesis of the knee with yttrium [90Y] colloid in rheumatoid arthritis and related indications.
    Kampen WU; Voth M; Pinkert J; Krause A
    Rheumatology (Oxford); 2007 Jan; 46(1):16-24. PubMed ID: 17065191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.
    Neill M; Studer G; Le L; McLean M; Yeung I; Pond G; Crook JM
    Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
    Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
    Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
    Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance and acceptance results of a palladium-103 permanent breast seed implant Phase I/II study.
    Pignol JP; Rakovitch E; Keller BM; Sankreacha R; Chartier C
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1482-8. PubMed ID: 18930602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcome and imaging changes after intraarticular (IA) application of etanercept or methylprednisolone in rheumatoid arthritis: magnetic resonance imaging and ultrasound-Doppler show no effect of IA injections in the wrist after 4 weeks.
    Boesen M; Boesen L; Jensen KE; Cimmino MA; Torp-Pedersen S; Terslev L; Koenig M; Danneskiold-Samsøe B; Røgind H; Bliddal H
    J Rheumatol; 2008 Apr; 35(4):584-91. PubMed ID: 18322991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients.
    Keyes M; Miller S; Moravan V; Pickles T; McKenzie M; Pai H; Liu M; Kwan W; Agranovich A; Spadinger I; Lapointe V; Halperin R; Morris WJ
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1023-32. PubMed ID: 19111402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.